Purchase Order 75N93023P00932
Award Date 7/10/23
Potential Completion Date 7/9/24
Potential Value $60K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $78,507.00 firm-fixed-price contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for Genscript Monoclonal Antibodies and Plasmid Services. This sole-source contract supports NIAID's Laboratory of Immunogenetics (LIG), which is expanding its work on isolating human monoclonal antibodies against COVID-19, malaria, and tuberculosis. The contract...
- Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...
- Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
- The National Institute of Allergy and Infectious Diseases awarded a $16,974.27 firm fixed price purchase order to Genscript USA Inc. for antibody gene synthesis and production services. The contract was awarded on August 26, 2020, with an ultimate completion date of February 6, 2021, and was performed at Genscript's facility in Piscataway, New Jersey. This award did not utilize any set-aside designation and represents a straightforward procurement of specialized molecular biology services...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $70,395.88 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the delivery of antibody production and gene synthesis services, including mammalian expression, cloning, and plasmid preparation, to support NIAID's biomedical research and public health initiatives....
- This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $17,391 purchase order to Genscript USA Inc. to produce a large scale run of recombinant, chimeric anti-Rickettsia monoclonal antibodies. Performance will take place in Piscataway, New Jersey over approximately two months from December 2023 through February 2024. The firm fixed price contract calls for Genscript to deliver the monoclonal antibodies to...
- This firm fixed-price purchase order, valued at $16,215, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has received numerous prime...
- This is a $1,147,346.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company. The contract is for customized biological services to support the development and testing of therapeutic antibody and vaccine candidates by NIAID's Vaccine Research Center. This includes services such as plasmid preparation, protein production, and gene to...